Bucillamine Prevents Afatinib-Mediated Inhibition of Epidermal Growth Factor Receptor Signaling
Naoyuki Nishiya(Iwate Medical University), Norikazu Omori(Iwate Medical University)
Cited by 1
Related Papers
JAK3 inhibitor VI is a mutant specific inhibitor for epidermal growth factor receptor with the gatekeeper mutation T790M
|World Journal of Biological Chemistry|2015|11